These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Sodium fluoride therapy.
    Author: Causse JR, Causse JB, Uriel J, Berges J, Shambaugh GE, Bretlau P.
    Journal: Am J Otol; 1993 Sep; 14(5):482-90. PubMed ID: 8122713.
    Abstract:
    As a medical treatment for otospongiosis-otosclerosis, sodium fluoride influences the underlying bony changes in the labyrinth so as to arrest or prevent the onset of hearing loss. Sodium fluoride is an enzyme inhibitor and reduces osteoclastic bone resorption and, if the dosage is more than 60 mg a day, may rebuild pseudohaversian bone.
    [Abstract] [Full Text] [Related] [New Search]